What is Avalo Therapeutics's net change in cash?

Avalo Therapeutics (AVTX) reported net change in cash of $9.21M in Q1 2026.

How has Avalo Therapeutics's net change in cash changed year-over-year?

Avalo Therapeutics's net change in cash increased by 197.4% year-over-year, from -$9.46M to $9.21M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Avalo Therapeutics AVTX Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

AbbVieABBV

$4.16B+1,293%

XencorXNCR

-$40M-2,970%

AbCellera Biologics Inc.ABCL

-$51.45M-1,849%

AnaptysBio, Inc.ANAB

$10.27M+142%

Absci CorporationABSI

-$11.39M-293%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's net change in cash?: Avalo Therapeutics (AVTX) reported net change in cash of $9.21M in Q1 2026.
How has Avalo Therapeutics's net change in cash changed year-over-year?: Avalo Therapeutics's net change in cash increased by 197.4% year-over-year, from -$9.46M to $9.21M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.